Results 321 to 330 of about 804,384 (336)

Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.

International Journal of Radiation Oncology, Biology, Physics, 1989
Jean M. Mefferd, S. Donaldson, M. Link
semanticscholar   +1 more source

Combined modality therapy of extrahepatic biliary system cancer.

International Journal of Radiation Oncology, Biology, Physics, 1990
B. Minsky, M. F. Wesson, J. Armstrong, N. Kemeny, B. Reichman, J. Botet, D. Nori   +6 more
semanticscholar   +1 more source

Improved survival in advanced Hodgkin's disease with the use of combined modality therapy

International Journal of Radiation Oncology Biology Physics, 1990
David Brizel, Jeffrey Crawford, Eric Winer   +2 more
exaly  

Effects of combined modality therapy of head and neck carcinoma on shoulder and head mobility

Journal of Surgical Oncology, 1989
P. Nowak, J. Parzuchowski, J. Jacobs
semanticscholar   +1 more source

Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: The importance of radiation field selection

International Journal of Radiation Oncology Biology Physics, 2007
Daniel Indelicato, Steven Feigenberg, Stephen Grobmyer   +2 more
exaly  

Is combined modality therapy necessary for advanced Hodgkin's disease?

International Journal of Radiation Oncology Biology Physics, 1997
Nancy Mendenhall, James W Lynch
exaly  

Combined Modality Therapy of Cancer

Radiology, 1974
openaire   +1 more source

Delayed gastrointestinal complications after combined modality therapy of childhood rhabdomyosarcoma

International Journal of Radiation Oncology Biology Physics, 1979
Charles B Pratt, C B Pratt, A P Kumar
exaly  

Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy

Journal of Voice, 1995
Gayle Woodson, G E Woodson
exaly  

Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC

Journal of Thoracic Oncology, 2018
Xiaofei Wang, Suresh Ramalingam, Karen Kelly   +2 more
exaly